Analyzing the Future of Anemia In Elderly Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What key factors are powering the surge in the anemia in elderly market right now?
In recent times, the anemia in elderly market has seen significant growth. The market is projected to expand from $2.75 billion in 2024 to $3.02 billion in 2025, with a compound annual growth rate (CAGR) of 9.7%. This surge during the historical period can be ascribed to factors like nutritional shortfalls, persistent illnesses, inflammation, bone marrow dysfunctions, and blood loss.
How fast Is the anemia in elderly market expected to grow, and what’s its future value?
The market size for anemia in the elderly is projected to experience robust growth in the coming years, reaching $4.32 billion in 2029 with a compound annual growth rate (CAGR) of 9.3%. The predicted growth during the forecast period is attributable to factors such as an aging population, increasing rates of chronic illnesses, advancements in diagnostic technology, heightened awareness about healthcare, and better treatment accessibility. Key trends for the forecast period encompass diagnostics powered by AI, wearable health tracking devices, sophisticated blood analysis instruments, the incorporation of telehealth, and individualized medicine solutions.
Get your anemia in elderly market report here!
https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report
What are the leading drivers of growth in the anemia in elderly market?
The expansion of the market for anemia in the elderly is anticipated to be spurred by the growing number of older individuals. The elderly population encompasses the rising figures and ratios of people aged 65 and above both globally and within any particular society. The reasons for this growth include longer life spans, falling birth rates, and the aging of substantial cohorts. Growth in the elderly demographic contributes to a higher frequency of age-related and chronic disorders, which are key triggers of anemia among senior citizens. This enhances the need for diagnosis, control, and remediation of anemia, driving overall market expansion. For example, data from the Office for National Statistics (ONS), a government organization in the UK, indicates that the count of people aged 65 or above in the UK rose to 12.7 million in 2022, up from 11 million in 2021. Consequently, the growth of the elderly population plays a pivotal role in driving the expansion of the anemia in elderly market.
What are the key segments defining the anemia in elderly market?
The anemia in elderly market covered in this report is segmented –
1) By Product Type: Tablets, Injectable
2) By Treatment: Iron Supplements, Erythropoietin Or Erythrocyte-Stimulating Agents, Vitamin B12 Supplements, Folic Acid Supplements
3) By Route Of Administration: Oral, Parenteral
4) By End User: Hospital pharmacy, Online Pharmacy, Retail pharmacy
Subsegments:
1) By Tablets: Iron Supplements, Vitamin B12 Supplements, Folic Acid Tablets, Erythropoiesis-Stimulating Agents (ESAs) Tablets
2) By Injectable: Iron Injections, Vitamin B12 Injections, Erythropoiesis-Stimulating Agents (ESAs) Injections, Folic Acid Injections
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20711&type=smp
Who are the key players steering the development of the anemia in elderly market?
Major companies operating in the anemia in elderly market are Johnson & Johnson, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc, Japan Tobacco Inc, Fresenius Medical Care AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, CSL Limted, Daiichi Sankyo Company Limited, Amag Pharmaceuticals, Akebia Therapeutics Inc, Pharmacosmos A/S, Rockwell Medical Inc, Bioage Labs Inc, Shield Therapeutics Plc, MegaPro Biomedical Co Ltd
What emerging trends are influencing the growth of the anemia in elderly market?
Leading businesses in the market for anemia treatments for the elderly are concentrating on technological enhancements like tailored therapies. These modifications are meant to streamline therapeutic methods, improve patient results, lessen side effects, and increase the overall effectiveness of healthcare. Personalized therapies, specifically, are medical procedures adjusted to each patient’s unique characteristics. For example, Cadila Pharmaceuticals, a pharmaceutical entity based in India, proclaimed in March 2024 that they have developed Redshot FCM, a unique iron injection aimed at curing iron insufficiency anemia in patients that cannot tolerate oral iron. This intravenous iron product provides the necessary iron dosage and showcases an exceptional safety profile. The injection employs an innovative Ferric Carboxymaltose recipe that boosts iron delivery and absorption. The creation of Redshot FCM highlights Cadila Pharmaceuticals’ commitment to advancing healthcare through the inception of customized therapies that accommodate individual patient profiles, leading to improved therapeutic results for iron deficiency anemia.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20711
Which regions are most influential in expanding the anemia in elderly market?
North America was the largest region in the anemia in elderly market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anemia in elderly market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Anemia and Other Blood Disorder Drugs Global Market Report 2025
Global Hematology Drugs Opportunities And Strategies Global Market Report 2025
https://thebusinessresearchcompany.com/report/hematology-drugs-global-market
Chemotherapy-Induced Anemia Global Global Market Report 2025
https://thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
